Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-25-002163
Filing Date
2025-01-14
Accepted
2025-01-14 16:35:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 8333526
2 annexh_001.jpg GRAPHIC 16282
3 annexi_001.jpg GRAPHIC 152589
4 annexi_002.jpg GRAPHIC 308087
5 annexi_003.jpg GRAPHIC 289064
  Complete submission text file 0001493152-25-002163.txt   9390599
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-281991 | Film No.: 25529769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 194 CANDELARO DRIVE #223 HUMACAO PR 00791
Business Address 194 CANDELERO DRIVE SUITE 223 HUMACAO PR 00791 (415)-592-7399
Aspire BioPharma Inc. (Filer) CIK: 0001995528 (see all company filings)

EIN.: 660991341 | State of Incorp.: PR | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-281991-01 | Film No.: 25529770